#In Vitro Lung Model Market Forecast

[factmrblog]

Medical Device Contract Manufacturing Market Growth Forecast Till 2033

The global medical device contract manufacturing market is projected to expand at a staggering CAGR of 11% from 2023 to 2033  . This market  is valued at USD 75 billion in 2023 and is projected to reach a value of  USD 214 billion  by 2033 . end.

Biological samples are tested using in vitro diagnostic (IVD) medical devices to evaluate a person's overall health. Increasing prevalence of cancer diseases is driving adoption of these devices, which adds to the demand for manufacturing services for IVD medical device development.

Download a sample copy of this report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=4834?VM

The readability score of the Medical Device Contract Manufacturing Market Demand report is good as it provides a chapter-by-chapter layout with each section broken into smaller sections.

Reports include graphs and tables showing the entire assembly. It is visually appealing by showing the confirmed and estimated values ​​of key segments in pictures. 

This Medical Device Contract Manufacturing Market Perspective report discusses important dynamics such as drivers, restraints, and opportunities for key players and competitive analysis of the Medical Device Contract Manufacturing market, along with key stakeholders and emerging players involved in product manufacturing.

The extended oral antibiotics market key trends analysis also provides the dynamics affecting future sales and demand during the forecast period.

Market player

Deviant Medical

Jeongsoo Holdings Corporation

front-line medical technology

Consort Medical PLC

Nipro Corporation

Flex Co., Ltd.

Zaville Co., Ltd.

cineco

Celestica Inc.

Notek Systems, Inc.

How can the Medical Device Contract Manufacturing market report make a difference to the revenue impact and strategies of businesses?

Fact.MR is committed to providing a comprehensive assessment of opportunities in different geographies and technology sectors. The study also provides neat data-driven insights into the medical device contract manufacturing market and how all segments are growing. Some of the ways research can have a measurable impact is by providing an evidence-based perspective on:

An index of the attractiveness of emerging product/technology types across a range of products in the medical device contract manufacturing market.

Microeconomic factors that may hinder the outlook for some key sectors

Funding of recent research and development (R&D) in key medical device contract manufacturing markets

New business models disrupting demand dynamics in key sectors

Regional markets to be future growth engines and industry trends to support them

Challenges to overcome that can give industry players a competitive edge

Major segments of research in the medical device contract manufacturing industry

·         By device:

In vitro diagnostic medical devices

Diagnostic imaging and medical equipment

drug delivery device

patient monitoring device

Minimize access to surgical instruments

Therapeutic patient aids

etc

·         By manufacturing type:

Raw material

Electronic products

Finished

·         By service:

prototype development

Finished product manufacturing

assembly and packaging

Testing and regulatory support services

molding and casting

etc

·         Application:

cardiovascular

Orthopedics

neurovascular

lung

oncology

laparoscopy

Urology and Gynecology

Radiology

etc

·         By region:

North America

europe

Asia Pacific

Latin America

Middle East and Africa

Get full access to all reports:

https://www.factmr.com/checkout/4834

The questionnaires answered in the Market Outlook for Detergent Polymers report are as follows:

What are the key strategies deployed by the large players to maximize Medical Device Contract Manufacturing market growth?

What are the major challenges faced by players in the medical device contract manufacturing market demand?

How will the medical device contract manufacturing market environment change during the forecast period with the advent of technological advancements?

What does the player bring to the table that is unique as a strategy and easy-to-imitate for new investors in the size of the medical device contract manufacturing market?

What difference does the insights and market forecasts provided in the Fact.MR report on detergent polymer demand make?

This study takes a closer look at major economic disruptions, with a focus on the recent COVID-19 pandemic disruption.

An assessment of key growth drivers highlights the attractiveness of new automation technologies and provides readers with insight into the prospects of these technologies over the forecast period.

This study attempts to provide a balanced view of opportunities in mature and most underperforming markets.

It scrutinizes industry trends that have shaped recent government policy.

We provide descriptions of major breakthroughs in every sector that could significantly change the course of the market.

It provides an incisive analysis of the socio-political environment in which key markets operate and how they will affect the profitability of the overall medical device contract manufacturing market.

We analyze how collaborations and partnerships between players from different industries will shape key growth dynamics in the near future.

Evaluate the role of different funding tiers for new growth vehicles in key regional markets. 

Contact: USA Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Phone: +1 (628) 251-1583 Email: sales@factmr.com

[pankajrathiblog-blog]

In Vitro Lung Model Market is Likely to Witness huge Growth | Industry Key Players - Epithelix Sàrl, MATTEK, LONZA, InSphero, Emulate, AlveoliX AG

The global in vitro lung model market is expected to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018. The market is estimated to grow with a CAGR of 16.2% from 2019-2027.

Driving factors of the in vitro lung model are significant growth in research funding, and increasing adoption of 3d model systems for in vitro studies. Also, growing research on lung diseases is likely to have a positive impact on the growth of the market in the coming years. Besides, rising healthcare expenditure, and advancements in cell culture techniques is likely to have a positive effect on the growth of the market in the forecast years.

Request Sample Copy of this Report @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011205&req_type=sample

The cases of asthma, lung cancer, and COPD has been growing across the globe at a significant rate. Thus there is a growing need to study lung diseases specifically. Since early 2010’s the practices of creating lab-grown organ buds, mostly referred to as ‘organoids’, have become more popular. These organ buds are miniature organ-like structures that are maintained in the lab, and researchers are able to grow these organoids, which resembles human body tissues. Lung diseases, like idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), is a significant cause of death and illness worldwide. A recently published report by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California developed a new system for building lung 3D organoids to model lung disease. Moreover, Lung cancer cell lines have made a significant contribution to lung cancer research and biomedical discovery. The high similarities between lung cancer cell lines and the lung tumor helps in discovering new drug molecules. Thus the growing research on lung diseases is expected to offer broad growth opportunities for the in vitro lung model market at the global level.

The global in vitro lung model market is segmented by type, and application. On the basis of type, the market is segmented into 2D and 3D. The 3D segment is expected to dominate the type segment market as 3D cell culture gives better phenotypes insights which are poorly reproduced in conventional 2D cell culture, Based on the application, market is segmented into drug screening, toxicology, 3d model development, physiologic research, stem cell research, and regenerative medicine. Toxicology segment is expected to dominate the application segment during the forecast period.

Ask For Discount @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011205&req_type=discount

Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), American Society of Clinical Oncology, American Type Culture Collection, Centers for Disease Control and Prevention, Canadian Lung Association and others.

About Us –

Intelligence Market Research & Consulting, LLP (IMRC) is a global provider of research reports, business intelligence & consulting services. We know and understand the importance of market research data for your institution. Therefore, we have teamed up with the leading research institutes and strategy specialists to bring to you the latest, niche and most relevant statistical research.

Contact Us –

699, Butler St. Suite 1007 Saugatuck, MI - 49453, United States Phone no.- +1 209 691 5657 Email id - sales@intelligencemarketresearch.com Website - www.intelligencemarketresearch.com

[marketsandmarketshealth]

In Vitro Lung Model Market Demand Analysis, Business Share, Strategies, Investment Opportunities, Revenue Expectation, Future Trends, Prominent Players

In Vitro Lung Model Market research report offer:

The global In Vitro Lung Model market is defined, along with an analysis of several influencing factors like drivers, constraints, opportunities, & challenges. Market risk analysis & industry trend analysis are also included in the In Vitro Lung Model market. The market competition landscape is defined, characterised, & analysed using Porter’s Five Force Analysis & SWOT analysis, with a focus on global primary manufacturers. Identification and analysis of micro and macro aspects that influence & will influence market growth in the global In Vitro Lung Model competitive landscape. A comprehensive list of key market participants in the global In Vitro Lung Model business. It gives a descriptive assessment of demand-supply side analysis in the worldwide In Vitro Lung Model market. A statistical analysis of certain major economic indicators The market is described using figures, charts, graphs, & drawings. COVID-19 Impact on In Vitro Lung Model market:

In the In Vitro Lung Model market, the research also reveals exclusive choices, difficult situations, & problematic scenarios. A series of concepts will aid readers in making decisions & strategizing for their future chances. Our challenges, adversity, and market concerns let our readers realise how businesses might save them. The novel coronavirus illness (COVID-19) problem is wreaking havoc on all service & manufacturing businesses due to severe declines in demand. The majority of workforces in this arena are at risk. As an outcome, a considerable number of originalities have shut down.

The global crisis has impacted every industry. COVID-19’s market impact has been closely monitored by our analysts. A separate section of the report focuses on the setbacks which happened throughout the crisis.

Get access to a free copy of our latest sample report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=78042820

Introduction of the global In Vitro Lung Model Market:

The intangible facts surrounding the key restraints, opportunities, & risks that are anticipated to affect the industry’s development during the forecast period are investigated in the In Vitro Lung Model Market report (2022-2026). Other assessments, like supply & demand, imports & exports, distribution networks, consumption, and production capacity, are all important in giving business owners, stakeholders, & field marketers a competitive edge over competitors in the same arena. Furthermore, the research evaluates the In Vitro Lung Model market competitors’ flaws & strengths in several categories. For business owners to establish real business plans, they must analyse previous & future major trends which are actively contributing to the growth of the In Vitro Lung Model industry.

A complete analysis of the global In Vitro Lung Model industry, as well as market segmentation by product type, applications, end-use, & region, is included in the report. The report includes a historical market dynamics analysis from 2022 to 2026, which will help readers compare past trends to current market scenarios, as well as key player contributions.

Regional Insights on In Vitro Lung Model market:

The several sections on regional segmentation provide information on the regional characteristics of the global In Vitro Lung Model Market. This chapter discusses the regulatory environment that will have an impact on the global market. It highlights the market’s political landscape & anticipates its impact on the worldwide In Vitro Lung Model industry. Global brands’ presence and availability, as well as the problems they face from fierce competition from local & domestic brands, the influence of domestic tariffs, and trade channels, are all considered. The In Vitro Lung Model report examines the five areas & their distribution by country:

North America – (U.S., Canada, and Mexico)

Europe – (U.K., Germany, France, Spain, Italy, Sweden, CIS Countries, and Rest of Europe)

Asia Pacific – (China, India, Japan, South Korea, Australia, ASEAN, and Rest of APAC)

Middle East & Africa – (South Africa, GCC Countries, Nigeria, Egypt, and Rest of ME&A)

South America – (Brazil, Argentina, Colombia, and Rest of South America)

Get access to a free copy of our latest Download PDF Brochure @

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78042820

Segmentation:  

Based on application, the market is segmented into applications of 2D models and 3D models. Applications of 2D models include drug discovery and toxicology, 3D model development, and basic research. The drug discovery and toxicology segment is expected to hold the largest share of 2D applications in 2018. The drug discovery and toxicology applications dominated the 2D application segment owing to the flexibility and high throughput capabilities of 2D cell models. Applications of 3D models include drug discovery and toxicology, physiological research, and stem cell research & regenerative medicine. The drug discovery and toxicology segment applications of 3D lung in vitro models are expected to dominate the market in 2018. The 3D cell models provide the relevant in vivo environment and reproducibility for drug discovery and toxicology applications.

Key Players:

The major players in the in vitro lung model market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

Will You Have Any Questions About This Report? Please Contact Us On:

https://www.marketsandmarkets.com/Market-Reports/lung-in-vitro-model-market-78042820.html

[awesomegeeta]

In Vitro Lung Model Market 2022, Competitive Landscape, Growth Prospects, Top Key Players, Industry Share and Forecast to 2028

This research report will give you deep insights about the In Vitro Lung Model Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry landscape, market size, market revenue, forecast, COVID-19 impact analysis, SWOT analysis, etc.

The in vitro lung model market was valued at US$ 185.80 million in 2018 and it is projected to reach US$ 701.81 million in 2027; it is expected to grow at a CAGR of 16.2% from 2019 to 2027.

Download Sample Pages of this research study at — https://www.theinsightpartners.com/sample/TIPRE00006695/

The key players profiled in this study includes

The state-of-the-art research on In Vitro Lung Model market, which is a detailed analysis of business space inclusive of the current market trends, competitive background, and size of the market. Encircling one or more parameters among analysis of the product, application potential, and global and regional growth strategies.

Type -Based Insights

In terms of type, the global in vitro lung model market is segmented into 2D and 3D. In 2018, the 3D segment held largest share of the market. Moreover, the same segment is estimated to register the highest CAGR during the forecast period.

Application-Based Insights

In terms of application, the global in vitro lung model market is segmented into drug screening, toxicology, 3D model development, stem cell research, physiologic research and regenerative medicine. In 2018, the toxicology segment held largest share of the market. The same segment is expected to register the highest CAGR during the forecast period.

Directly Purchase a copy of this research study at — https://www.theinsightpartners.com/buy/TIPRE00006695/

[healthcareinsight]

In Vitro Lung Model Market Size and Growth Analysis Report 2023

[Report of 100 pages] Cell models that represent normal or pathological lung physiology are known as lung in vitro models. When these cells are grown in a monolayer on a petri dish, they are referred to as 2D in vitro models. 3D models have a three-dimensional architecture and are supported by scaffolds and supports. 3D models are available commercially as ready-to-use in vitro models and can be built in-house utilising consumables.

The global in vitro lung model market was valued at USD 166.5 million in 2017 and is predicted to grow at a CAGR of 17.5 percent to USD 427.4 million by 2023.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78042820

Business Information Additional market players will be profiled and analysed in detail (Up to 5)

The lung in vitro models market is expected to grow at a CAGR of 17.5 percent from USD 190.5 million in 2018 to USD 427.4 million in 2023. The development of innovative 3D in vitro models, as well as an increasing focus on providing alternatives to animal testing models, are driving the growth of this industry.

The report breaks down the market for lung in vitro models by type, application, and geography. The in vitro lung model market is divided into two types: 2D cell models and 3D cell models. In-house and marketed 3D cell models are the two types of 3D cell models (ready-to-use). Due to the growing demand for efficient lung in vitro models that replicate in vivo physiology, the 3D cell models segment is expected to develop at the quickest rate throughout the forecast period.

The market is divided into two types of applications: 2D models and 3D models. Drug discovery and toxicity, 3D model development, and basic research are all applications of 2D models. In 2018, the drug discovery and toxicology industry is projected to have the most 2D applications. Because of the versatility and high throughput capabilities of 2D cell models, drug development and toxicology applications dominated the 2D application area. Drug discovery and toxicity, physiological research, and stem cell research and regenerative medicine are all applications of 3D models. In 2018, the market for 3D lung in vitro models is likely to be dominated by drug development and toxicology applications.For drug research and toxicity applications, 3D cell models provide the relevant in vivo environment and reproducibility.

Request Sample:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=78042820

The major players in the lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

[cricsart]

Most EGFR mutations found in adenocarcinoma are located in the tyrosine kinase domain. The most frequently encountered mutations are in-frame deletions in exon 19 (around 45%) and a point mutation in exon 21 (L858R), which together account for over 85% of described mutations. These mutations strongly correlate with NSCLC patients responding to EGFR therapies such as the tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib, afatinib, and icotinib.

[cool-akashy-maximize]

In Vitro Lung Model Market Market Production Analysis, Opportunity Assessments, Industry Revenue, Advancement Strategy and Geographical Market Performance Forecast to 2027

In Vitro Lung Model Market: size was valued at USD 166 million in 2019 and is expected to reach USD $483 million by 2026, at a CAGR of 18.2% during the forecast period.

In Vitro Lung Model Market Overview:

The report covers the current estimate and forecast for in Vitro Lung Model Market on a global and regional level. The report provides an in-depth analysis of the In Vitro Lung Model Market for the period 2019 – 2026, wherein 2019 is the base year and the period from 2020 to 2026 is the forecast period. Data for 2016- 2018 has been included as historical information.

In Vitro Lung Model Market Report Scope the latest industry report on the global In Vitro Lung Model market assesses the opportunities and current market landscape, offering insights and updates on the corresponding segments for the forecasted period of 2021-2027. The report contains a complete analysis of major market dynamics as well as detailed information on the global In Vitro Lung Model  market's structure. This market research report provides unique insights into how the global In Vitro Lung Model  market is expected to grow from 2021 to 2027.

The primary goal of the In Vitro Lung Model  market research is to provide detailed information on market opportunities that are assisting in the transformation of global In Vitro Lung Model  enterprise. Report  provide projected growth rates along with the compound annual growth rate (CAGR) for forecasted period to enable readers to better understand the monitoring and assessment of the global In Vitro Lung Model  market, as well as to discover lucrative opportunities in the market.

Request for free sample: https://www.maximizemarketresearch.com/request-sample/85854

In Vitro Lung Model Market Scope:

Maximize Market Research, report provide overall market insights for manufacturers, suppliers, distributors, and investors in the global In Vitro Lung Model market. The information and data offered in the report may be used by all stakeholders in the global In Vitro Lung Model market, as well as industry professionals, researchers, journalists, and business researchers.

Maximize Market Research, report provides a unique research approach to conduct detailed research on the global In Vitro Lung Model  market and make conclusions on the market's future growth factors. Primary and secondary research methodologies are combined in the research approach to assure the authenticity and validity of the conclusions in this report.

The report discusses the In Vitro Lung Model market's drivers, restraints, opportunities, and challenges. The research helps to identify the market growth drivers and determining how to utilize these factors as strengths. Restraints can assist readers in identifying traits that are restricting the In Vitro Lung Model market, as well as reducing them before they become an issue.  This will assist readers in comprehending the aspects that will influence your ability to capitalise on possibilities.

In Vitro Lung Model Market Segmentation:

An increase in research and development of new drugs and rising demand for in vitro lung models for lung transplantation are anticipated to grow the global market. Government facilities and expenditure for research and development across the pharmaceutical sector, biochemistry labs, national cell science centers are also boosting the global long model market. Human model systems that reliably and accurately recapitulate the complexities of human biology in vitro should help to improve our understanding of and ability to treat human lung disease.

Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-in-vitro-lung-model-market/85854/

In Vitro Lung Model Market Key Players:

• Epithelix • MatTek Corporation • Lonza • ATCC • InSphero • Emulate • AlveoliX AG • Oncotheis • Insphero • TissUse • Mimetas • CN Bio Innovations • Thermo Fisher Scientific Inc. • PromoCell GmbH • Merck KGaA • Hoziron Discovery Group plc

The competitive landscape shows the market share of major key competitors, as well as their key development plans and current financial performance over the previous five years. This information is anticipated to help businesses understand their competitors on a global level. Furthermore, the reports feature company profiles, product offers, critical financial data, country-level research, and a synthesis of demand and supply variables that influence market growth.

In Vitro Lung Model Market Regional Analysis:

Geographically, In Vitro Lung Model market report is segmented into several key regions are as follows,

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

North America (the United States, Mexico, and Canada.)

South America (Brazil etc.)

The Middle East and Africa (GCC Countries and Egypt.)

Furthermore, the study covers market size, growth rate, import and export, as well as country-level analysis, integrating the demand and supply forces of the In Vitro Lung Model market in these countries, which are impacting market growth.

COVID-19 Impact Analysis on In Vitro Lung Model Market:

COVID-19's global influence on the In Vitro Lung Model market was examined in this research. During this crisis, the report examines the In Vitro Lung Model market's alternatives, demanding conditions, and difficult possibilities in detail. In terms of funding and market expansion, the paper briefly examines the COVID-19's merits and limitations. The study also contains a set of concepts that should aid readers in developing and planning company strategies.

The report considers consultations to overcome past disruptions and foresees potential ones in order to improve preparation. Businesses can use the frameworks to design their strategic alignments in order to recover from such disruptive trends. Maximize Market Research analysts can also assist readers in breaking down a complex circumstance and bringing resiliency to a situation that is uncertain.

About Us:

Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors.

Contact Us:

MAXIMIZE MARKET RESEARCH PVT. LTD.

3rd Floor, Navale IT Park Phase 2,

Pune Bangalore Highway,

Narhe, Pune, Maharashtra 411041, India.

Email: sales@maximizemarketresearch.com

Phone No.: +91 20 6630 3320

Website: www.maximizemarketresearch.com

[industry365]

Microfluidics Market Key Players, 2028 Product And Production Information Analysis And Forecast

The global microfluidics market size is expected to reach USD 55.18 billion by 2028 according to a new study by Polaris Market Research. The report “Microfluidics Market Share, Size, Trends, Industry Analysis Report, By Material (Silicon, Glass, Polymer, PDMS); Technology (Medical, Non-medical); By Application; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The major factors driving the growth of the market are the need for miniaturization of PoC devices and the need to develop new 3D culture models that can mimic the pathophysiology of human organs for disease models and drug screening.

The use of the product will greatly enhance PoC devices in speed and accuracy. The increased incidences of chronic diseases such as diabetes led to the increased use of PoC devices as these devices can help monitor the disease in a home setup.

New culture models such as Organ-on-a-chip model systems are developed using microfluidic technology. These systems can mimic the physiology of organs such as lungs, kidneys, and others. They have applications in disease modeling to understand the pathophysiology of the disease and in drug screening as currently available in vitro platforms for drug screening have limitations.

Download sample: https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-sample

In 2021, LumiraDx received approval for a microfluidic immunofluorescence assay to detect SARS-CoV-2 antigen in Japan and Brazil. In January 2021, LexaGene announced the launch of the MiQLab system from research-only use to POC use to detect the SARS-CoV-2 virus after receiving emergency use authorization (EUA) in the U.S.

COVID-19 pandemic is expected to further fuel the growth of the global industry. There is a time-bound urgency to develop rapid diagnostic tests and screen and develop drugs in pandemic times to bring down the pandemic under control. The product-based PCR will help significantly in the diagnosis of disease.

Market Participants such as Roche Ltd, PerkinElmer, Agilent Technologies, Inc., Danaher Corporation, Abbott Laboratories, Life Technologies Corporation, Thermo Fisher Scientific, Biomerieu, Illumina, Inc., Qiagen, Bio-Rad Laboratories, Elveflow, Micronit Micro Technologies B.V., Cellix Ltd., and Fluidigm Corporation are few key players operating in the global industry.

Get Discount offer: https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-discount-pricing

Polaris Market Research has segmented the microfluidics market report on the basis of technology, material, application, and region:

Microfluidics, Technology Outlook (Revenue – USD Million, 2016 – 2028)

Medical

PCR & RT-PCR

Gel Electrophoresis

Microarrays

Enzyme-linked Immunosorbent Assay (ELISA)

Others

Non-medical

Microfluidics, Material Outlook (Revenue – USD Million, 2016 – 2028)

Silicon

Glass

Polymer

Polydimethylsiloxane (PDMS)

Others

Microfluidics, Application Outlook (Revenue – USD Million, 2016 – 2028)

Lab-On-A-Chip

Organs-On-Chips

Continuous Flow Microfluidic

Optofluidics and Microfluidic

Acoustofluidics and Microfluidics

Electrophoresis and Microfluidics

Microfluidics, Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

German

UK

France

Italy

Spain

Netherlands

Austria

Russia

China

India

Indonesia

Japan

Malaysia

South Korea

Argentina

Brazil

Mexico

Israel

Saudi Arabia

South Africa

UAE

Buy Now: https://www.polarismarketresearch.com/checkouts/9111

[marketresearchstrategy]

Advanced Wound Care  Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2028

Growing awareness regarding wound management globally is driving revenue growth of the market

The global advanced wound care market size reached USD 10.4 Billion in 2020 and is expected to reach USD 21.77 Billion in 2028 and register a CAGR of 9.7% over the forecast period, according to latest analysis by Reports and Data. Growing demand for novel and advanced wound care products due to rising incidences of trauma and burns injuries across the globe is one of the primary factors driving the advanced wound care market revenue growth. Additionally, robust technological advancements in wound care products, several government initiatives to improve healthcare infrastructure, and rising funding for wound care research worldwide are some other crucial factors contributing to the revenue growth of the global market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1332

The pharmaceutical and healthcare sector has witnessed drastic changes in the recent years primarily due to growing prevalence of diseases, technological advancements in medicine, and increasing investments in research and development activities. The global Advanced Wound Care  market is expected to reach USD XX Billion in 2028 from USD XX Billion in 2020 at a CAGR of XX%. Increasing investments in pharmaceutical sector, drug discovery developments, funding by public and private sectors are also boosting market revenue growth. In addition, availability of latest technology in several developed and developing countries, improvements in healthcare infrastructures and growing adoption of rapid testing and point-of-care diagnosis are further fueling market growth. In addition, constant demand for various medications, and devices is expected to continue to benefit leading companies during the ongoing pandemic. Increasing demand for home care settings, growing need for early diagnosis and increasing adoption of precision medicine are fueling market growth.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1332

Some Key Highlights from the Report:

Major companies operating in the market are Smith & Nephew Plc. (UK), Mölnlycke Health Care AB (Sweden), Baxter International (U.S.), 3M Company (U.S.), Integra LifeSciences Holdings Corporation (U.S.), ConvaTec Group Plc (UK), Coloplast A/S (Denmark), Medtronic Plc (Ireland), Ethicon Inc. (U.S.), PAUL HARTMANN AG (Germany), MiMedx Group (U.S.), and DeRoyal Industries (U.S.).

To know more about the report @ https://www.reportsanddata.com/report-detail/advanced-wound-care-market

The report further offers insights of the market segments based on product type, applications, end users, and 5 major regions covered in the global Advanced Wound Care  market.

Advanced Wound Care  Market Segmentation:

Product Outlook (Revenue, USD Billion, 2018 - 2028)

Foam Dressings

Hydrocolloid Dressings

Film Dressings

Alginate Dressings

Hydrogel Dressings

Collagen Dressings

Hydrofiber Dressings

Wound Contact Layers

Superabsorbent Dressings

Other Advanced Dressings

NPWT Devices & Accessories

Debridement Devices & Accessories

Wound Assessment & Monitoring Devices

Other Devices & Accessories

Wound Type Outlook (Revenue, USD Billion, 2018 - 2028)

Surgical & Traumatic Wounds

Diabetic Foot Ulcers

Pressure Ulcers

Venous Leg Ulcers

Burns & Other Wounds

End Use Outlook (Revenue, USD Billion, 2018 - 2028)

Hospitals, ASCs and Wound Care Centers

Homecare Settings

Other End Users

Regional Outlook:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

Mexico

Germany

U.K.

Italy

France

BENELUX

Rest of Europe

China

India

Japan

South Korea

Rest of APAC

Brazil

Rest of LATAM

Saudi Arabia

A.E.

South Africa

Rest of MEA

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1332

Thank you for reading our report. Get in touch with us to know more about the customization feature and our team with provide you the best suited report as per your need.

Browse more related reports:

Browse more related reports:

Neuroscience Antibodies and Assays Market

Cochlear Implant Market

Creatinine Measurement Market

Lung In Vitro Model Market

C-Reactive Protein Testing Market

[krishnaimrreport]

Global Lungs in Vitro Market Overview 2021: Global Demand Analysis & Opportunities Outlook 2026 ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero, Cn Bio

The Global Lungs in Vitro Market is expected to reach US$ 789 Million by 2027, with a CAGR of 16.9%from 2020 to 2027

Lung in vitro models are defined as cell models that represent a normal or diseased lung physiology. These cells when constructed in a monolayer on a petri plate are called 2D in vitro models. 3D models have a 3-dimensional architecture and use supports and scaffolds to maintain their structure..

This report provides a thorough overview of the competitive landscape of global Robotic Pet Dogs Market and a detailed business profile of notable players in the market. Using industry standard tools like Porter's five force analysis and SWOT analysis, analysts in the report measure threats and weaknesses in key companies. The market report covers all key parameters such as product innovation, market strategy for leading companies, market share, revenue generation, the latest research and development and market expert perspectives.

Key Players Mentioned: ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero, Cn Bio

For Right Perspective & Competitive Insights, Request a Sample @:

https://www.imrmarketreports.com/request/18615

Increased competition between the organizational and non-organization sectors and high raw material costs are expected to curb future market growth. The growing interest in segment products and demand generation in developing countries will further accelerate market growth during the forecast period. This report covers all aspects of the Lungs in Vitro industry, including market sales, technical thinking, and business profiles.

Product Segment Analysis: 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, Inhouse 3D Cell Models

Application Segment Analysis: Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine

Regional Segment Analysis: USA, Europe, Japan, China, India, South East Asia

The Global Lungs in Vitro Market Report was produced through extensive primary and secondary studies. The report also focuses on qualitative and quantitative assessments by analyzing data collected from industry analysts and market participants across key points in the industry's value chain, growth aspects, utilization and manufacturing capabilities.

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!!:

https://www.imrmarketreports.com/discount/18615

This report analyzes the factors affecting the Lungs in Vitro Market in terms of supply and demand and further assesses the market dynamics affecting the market during the forecast period e.g. drivers, restraints, opportunities and future trends. The report also provides Porter's five forces analysis of global scenarios.

The Report allows you to: - Formulate significant competitor information, analysis and insights to improve your R&D strategy. - Identify potentially strong product portfolios emerging players and create effective response strategies to gain a competitive edge. - Identify and understand important and diverse types of Lungs in Vitro  under development - Develop market entry and market expansion strategies - Identify the main players with the most promising pipeline to effectively plan mergers and acquisitions. - In-depth analysis of the product's current development phase, area, and expected release date.

Key Points covered in the Lungs in Vitro Market Report Coverage: 1 Market share study of the top manufacturing players 2 Market share debts for the regional and country level segments 3 Premeditated references for the new competitors 4 Competitive landscaping planning the key common trends 5 Tactical endorsements in key business segments based on the market estimations 6 Market Trends (Constraints, Drivers, Opportunities, Threats, Challenges, recommendations and Investment Opportunities) 7 Company profiling with detailed strategies, financial and latest developments 8 Supply chain trends mapping the latest technological advancements

Get More Insights:

https://www.imrmarketreports.com/request/18615

About Us:

IMR Market Reports is a visionary market research company who is ready to assist their clients to grow their business by offering strategies through our market research reports for gaining success. We have a well experienced team, who work efficiently and provides complete excellent research data in a complete sync to provide overall coverage and accurate market insights on various industries.

[factmrresearch1]

Lifescience Reagent Market Insights

Increasing prevalence of infectious disease, which requires early diagnosis is creating the opportunity for the biotechnology industry players to produce effective reagents to carry out various diagnostic tests. Moreover, launching of new diagnostic tests and assays is contributing to the lifescience reagents market share. For instance, in April 2019, Roche launched Ventana HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2 biomarker in breast and gastric cancer patients to determine the eligibility for the targeted drug trastuzumab (Herceptin). The new reagent is intended for in vitro diagnostic (IVD) use.

The global lifescience reagent market was valued at US$ 33,754.0 million in 2017, and is expected to witness a CAGR of 7.3% during the forecast period (2018–2026).

Figure 1. Global Lifescience Reagent Market value Analysis (US$ Mn) and Forecast and Absolute $ Opportunity

Source: Coherent Market Insights Analysis (2019)

Increasing number of product launches is expected to drive growth of global lifescience reagent market

Increasing product launches for reagents to assist different types of diagnostics tests and research purpose is expected to drive the global lifescience reagent market growth. For instance, in March 2019, Dolomite Bio, a provider of single cell technologies, launched a new scRNA-Seq reagent kit to expand the Nadia Instrument portfolio. The new scRNA-Seq reagent kit is designed to enable the generation of PCR­amplified cDNA libraries on the Nadia Instrument, allowing high throughput gene expression profiling of heterogeneous cell populations.

Moreover, in October 2016, Beckman Coulter’s lifescience division launched Clearllab LS Lymphoid Screen Reagent. It is CE-marked and 10-colour containing 12 antibody reagent combinations used for leukemia and lymphoma analysis. The new approach is designed to provide results with a faster turnaround time (TAT). ClearLLab has been specifically designed for identification of haematolymphoid cells on the Beckman Coulter’s Navios flow cytometer.

Increasing acquisitions among biotechnology industry players is contributing to the global lifescience reagent market during the forecast period. For instance, in February 2017, Anatrace (StoneCalibre’s portfolio company), acquired Molecular Dimensions Ltd. Molecular Dimensions Ltd is the U.K.-based supplier of modern screens, reagents, and other consumables and instrumentation for structural biology research. With this acquisition, Anatrace intended to establish its presence in Europe and expand its position in the structural biology product portfolio.

Global Lifescience Reagent Market- Regional Analysis

North America is expected to witness lucrative growth in global lifescience reagent market, owing to growing initiatives taken by market players to establish their product portfolio in North American countries. For instance, in May 2018, Grifols received the U.S. Food & Drug Administration (FDA) licensing approval to commercialize a range of antisera reagents designed for routine and complex immunohematology testing in the U.S.

Moreover, in 2016, LabX Media Group, Inc. acquired 1DegreeBio Inc., (www.1degreebio.com), the antibody and reagent search engine for lifesciences. With this acquisition, LabX Media Group introduced 1DegreeBio Inc. to its portfolio of established brands. The website ‘www.1degreebio.com’ includes a database of lifescience reagents and kits including quality validation data, citation history, as well as antibody reviews and community ratings.

Asia Pacific is also expected to drive the global lifescience reagent market growth, owing to presence of key players in this regions. For instance, in December 2015, Sekisui Chemical, a Japanese company, acquired Eidia, a subsidiary company of Eisai, to develop and market reagents, especially diagnostic reagents, for curbing cancer and rheumatism. Eisai was the manufacturer, importer, and marketer of chemical equipment, clinical diagnostic reagents, clinical analyzers, and laboratory reagents. Sekisui purchased the Eidia from Eisai for US$ 18 million.

Europe is expected to show significant lifescience reagent growth rate, owing to increasing number of approvals from the European Union for the diagnostics reagents and assays. For instance, in March 2017, HTG Molecular Diagnostics, Inc. received CE marking in the European Union for its HTG EdgeSeq ALKPlus Assay EU. The company is provider of instruments, reagents, and services for molecular profiling applications. HTG EdgeSeq ALKPlus Assay EU is an in vitro diagnostic assay used to measure and analyze mRNA ALK gene rearrangements in formalin-fixed, paraffin-embedded lung tumor specimens from patients previously diagnosed with non-small cell lung cancer (NSCLC).

Figure 2: Global Lifescience Reagent Market Value (US$ Mn), By Region

Source: Coherent Market Insights Analysis (2019)

Global Lifescience Reagent Market - Competitive Landscape

Key players operating in the global lifescience reagent market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Siemens Healthineers, Becton, Dickinson and Company, Agilent Technologies Inc., Perkin Elmer Inc., Waters Corporation, Ortho Clinical Diagnostics, bioMérieux SA, and Sysmex Corporation.

 Buy now the market research report here:

https://www.coherentmarketinsights.com/insight/buy-now/2681

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

 What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

Request the sample copy of here: https://www.coherentmarketinsights.com/insight/request-sample/2681

Download the PDF Brochure here:

https://www.coherentmarketinsights.com/insight/request-pdf/2681

 Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: 

https://www.coherentmarketinsights.com/market-insight/lifescience-reagent-market-2681

[kunalcmi]

CANCER DIAGNOSTICS MARKET ANALYSIS (2020-2027)

Tumor biomarkers tests use in diagnosis of cancer include, prostate specific antigen (PSA), circulating tumor cells (CTC), Alfa-fetoprotein test (AFP), CA-19 test for pancreatic cancer, HER-2 test, BRCA test, ALK test for lung cancer, carcioembryonic test (CEA), EGFR mutation test, and RAS mutation test.

The global cancer diagnostics market is estimated to account for US$ 45,106.5 Mn in terms of value and is expected to reach US$ 83,641.9 Mn by the end of 2027.

 Global Cancer Diagnostics Market: Drivers

Increasing prevalence of cancer is expected to propel growth of the global cancer diagnostics market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Moreover, R&D in cancer diagnostics is also expected to aid in growth of the market. For instance, in January 2020, researchers from Universidade do Porto, Portugal, reported assessment of the role of O-glycosylation using glycoengineered gastric cancer models in the detection of CD44v9 – a major protein splice variant isoforms expressed in human gastrointestinal cancer cells—by monoclonal antibodies. 

Biopsy held dominant position in the global cancer diagnostics market in 2019, accounting for 35.1% share in terms of value, followed by Imaging and Tumor Biomarkers Tests, respectively.

 Figure 1. Global Cancer Diagnostics Market Share (%), by Value, by Test Type, 2019

Global Cancer Diagnostics Market: Restraints

Inadequate reimbursement policies are expected to hinder growth of the market. There have been various advancements in radiology with regard to imaging equipment in the recent past. However, most medical insurance companies do not offer reimbursement for procedures using Computer-aided Detection (CAD). As a result, people tend to choose conventional methods for diagnosis such as biopsy, pathological test or conventional imaging methods such as mammography, and MRI procedures.

Moreover, high price of cancer detection software is also expected to hamper growth of the market. Computer-aided Detection (CAD) software is available with a one-year license and hospitals have to renew it each year. Moreover, some insurance providers are opting out of the CAD procedure reimbursement as it is deemed extravagant and not preferred by senior radiologists

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/4029

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/4029

 Global Cancer Diagnostics Market: Opportunities 

Development of biopsy platforms for companion animal cancers is expected to offer lucrative growth opportunities for players in the global cancer diagnostics market. For instance, in January 2020, Zomedica Pharmaceuticals Corp., a veterinary diagnostic and pharmaceutical company, announced completing the development and manufacturing of its reference lab cancer liquid biopsy platform for canine cancers.

Moreover, use of AI in early detection of cancer is also expected to aid in growth of the market. For instance, Freenome, an AI genomics company based in the U.S., is focused on developing blood tests to detect the body’s early-warning signs of cancer, using AI. In October 2018, the company presented early data in R&D for using machine learning to detect colorectal cancer at its earliest stages.

The global cancer diagnostics market was valued at US$ 41,542.4 Mn in 2019 and is forecast to reach a value of US$ 83,641.9 Mn by 2027 at a CAGR of 9.2% between 2020 and 2027.

Figure 2. Global Cancer Diagnostics Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

Major players in the market are focused on adopting partnership strategies to enhance their market share. For instance, in February 2020, Foundation Medicine, Inc. and Chugai Pharmaceutical, Ltd. collaborated with National Cancer Center (NCC) for the use of FoundationOneLiquid, Foundation Medicine’s laboratory-developed liquid biopsy test, in the third stage of SCRUM-Japan, a cancer genomic screening consortium in Japan.

Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in January 2020, Quest Diagnostics acquired Blueprint Genetics to expand its product portfolio in genetic and rare diseases.

Global Cancer Diagnostics Market: Competitive Landscape

Major players operating in the global cancer diagnostics market include, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens AG, Bio Rad Laboratories Inc., GE Healthcare, Illumina, Inc., Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Agilent Technologies, Inc., Aurora Imaging Technologies, Inc., Quest Diagnostics

Global Cancer Diagnostics Market: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in May 2020, Myriad Genetics, Inc. received the U.S. Food and Drug Administration (FDA) approval for its BRACAnalysis CDx test as a CDx for Lynparza in homologous recombination repair-mutated metastatic castration-resistant prostate cancer.

Major players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in October 2019, Illumina, Inc. partnered with QIAGEN N.V. to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics, for patient management.

 About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

 What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/market-insight/cancer-diagnostics-market-4029

[sandlerresearch]

Bordetella Pertussis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) published on

https://www.sandlerresearch.org/bordetella-pertussis-tests-in-vitro-diagnostics-global-market-analysis-and-forecast-model-covid-19-market-impact.html

Bordetella Pertussis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)

Bordetella Pertussis Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Summary

Bordetella Pertussis Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Bordetella Pertussis Tests market for the year 2020 and beyond. Bordetella pertussis, also called whooping cough, is an upper respiratory infectious disease caused by Bordetella pertussis bacteria. The disease spreads person to person by inhaling the tiny droplets of bacteria when an infected person coughs or sneezes. The B. pertussis bacteria enters the lungs, attaches to the upper part of the respiratory tract and releases toxins, which cause excessive coughing due to swelling and irritation. Bordetella Pertussis Tests Model covers NAATs, EIA and multiparameter NAAT.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Bordetella Pertussis Tests and evolving competitive landscape – – Insightful review of the key industry trends. – Annualized total Bordetella Pertussis Tests market revenue by segment and market outlooks from 2015-2030. – Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights – – Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market. – SWOT analysis for Bordetella Pertussis Tests market. – Competitive dynamics insights and trends provided for Bordetella Pertussis Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. – Country specific overview of the healthcare system. – Country specific reimbursement policies. – Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Meridian Biosciences, Luminex Corp, Quidel Corporation , Diasorin Inc, Hologic Inc, bioMerieux SA and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for – – CMO executives who must have deep understanding of the Bordetella Pertussis Tests market place to make strategic planning and investment decisions. – Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. – Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to – – Understand the impact of COVID-19 on Bordetella Pertussis Tests market. – Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. – Develop business strategies by understanding the trends shaping and driving Bordetella Pertussis Tests market. – Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Bordetella Pertussis Tests market in the future. – Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. – Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. – Track device sales in the global and country-specific Bordetella Pertussis Tests market from 2015-2030. – Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

[marketresearchstrategy]

Animal Genetic Products Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2027

The Global Animal Genetic Products Market is forecast to reach USD 7.13 Billion by 2026, according to a new report by Reports and Data.  The market is forecasted to witness an increase in demand due to increase in consumption of animal proteins and rapid increase in urbanization across the globe. To fulfill the rising demand, producers have inclined towards animal genetics to breed high-quality livestock and secure large-scale production. The demand for genetic testing has increased over the years due to the rise in animal diseases, increasing the prevalence of zoonotic diseases and a rise in the trend of companion animals.

Increasing investment in research and development of new drugs and vaccines by both government and private companies is expected to propel the market. The high cost of animal testing, low returns on R&D, and concerns about the adverse effect of genetic engineering on animals are some of the restraints limiting the growth of the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1344

The Animal Genetic Products market report offers key insights into market scope along with emerging growth opportunities over the forecast period. The report also provides information about the competitive landscape of the global Animal Genetic Products market. The global Animal Genetic Products market is fragmented due to presence of numerous key players on a global and regional scale. Key players are focused on mergers and acquisitions, joint ventures, collaborations, partnerships, and research and development activities to expand their product portfolio and gain a robust footing in the market.

Key Companies Operating in the Animal Genetic Products Market and profiled in the report are:

Genus Plc, Hendrix Genetics BV, Alta Genetics, CRV Holdings B.V., Neogen Corporation, VatGen, Animal Genetics Inc., Zoetis, Urus, and Envigo

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1344

The report provides a significant assessment of the recent market trends, revenues, segments, and key regions across the globe. The regional analysis covers major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report analyzes key regions for production and consumption patterns, import/export, market share, revenue contribution, growth rate, and supply and demand ratio for the forecast period 2021-2028. It also discusses the impact of government regulations, macro- and micro-economic factors, and economic growth of the region on overall market growth.

Regional analysis covers:

North America (U.S.A., Canada)

Europe (U.K., Italy, Germany, France, Rest of Europe)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report @ https://www.reportsanddata.com/report-detail/animal-genetic-products-market

By Live Animals (Revenue, USD Billion; 2017-2027)

Porcine

Poultry

Canine

Bovine

Others

By Genetic Material (Revenue, USD Billion; 2017-2027)

Embryo

Semen

By Testing Services (Revenue, USD Billion; 2017-2027)

Genetic Diseases tests

Genetic Trait Tests

DNA Typing

Others

Key Questions Answered by the Report:

What was the market size of the global Animal Genetic Products market in 2020? At what rate is the market expected to grow over the forecast period?

What are the key growth driving and restraining factors of the Animal Genetic Products market?

What are key opportunities and growth prospects of the Animal Genetic Products industry is expected to witness over the forecast period?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

Which region is expected to dominate the market growth over the forecast period?

Which segments are expected to register lucrative growth over the forecast period?

What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1344

Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.

Browse more Reports:

Browse more related reports:

Neuroscience Antibodies and Assays Market

Cochlear Implant Market

Creatinine Measurement Market

Lung In Vitro Model Market

C-Reactive Protein Testing Market

[ketan-wagh121-blog]

2020-2026 Report on Organ-on-Chip Market by Player, Region, Type, Application, Sales Channel

Global Organ-on-Chip Industry

Overview

An organ-on-chip, commonly known as OOC, is a form of multi-channel 3D microfluidic cell culture chip. It is one of the varieties of the artificial organ that simulates activities, mechanics, and physiological and physical responses of the organs and organ systems. It is a kind of microfluidic cell culture device that comprises of perfused chambers. This chip develops a thin channel for the purpose of blood and airflow in organs, such as the gut, lung, liver, heart, and other crucial organs. Such devices offer varying organ functionalities, which are not possible utilizing formal 2D and 3D culture systems.

Try Sample of Global Organ-on-Chip Market @ https://www.wiseguyreports.com/sample-request/3672024-global-organ-on-chip-market-research-and-forecast-2018-2023

Organ-on-chip offers a broad range of applications, such as infection modelling, phenotypic screening, and patient stratification. According to the market study, enhanced demand for advanced and efficient alternatives for animal testing, a requirement for timely detection of drug toxicity, improvement in R&D and product innovation strategies, and advancements in technology are expected to drive the global OOC market. Likewise, some of the prominent pharmaceutical organizations have shown their interest in investing in drug repurposing employing organs-on-chips models. The increased demand for personalized medication and a broad range of applications of OCD beyond the pharmaceutical vertical are the factors presenting growth opportunities for global market players.

As a result of advanced R&D and product innovation strategies, there is a considerable surge in product launches by leading market players. These activities are intended to expand the organization's portfolio, which is further expected to support market growth. The pharmaceutical industry is encountering several challenges due to the surging cost and decreasing efficiency of drug R&D. Therefore, there is a significant requirement for modern testing strategies for generating valid predictions of drug potency. Organ-on-chip devices have the capability to serve as an enabling platform for the identification and validation of effectiveness, safety, and strength of potential drugs, thus improving the possibilities of success in clinical trials.

Market Segmentation

The global organ-on-chip market can be analyzed on the basis of product types, manor offerings, crucial application areas, regional markets, and prominent market players.

Based on the product type, the global Organ-on-chip market can be segmented into-

Liver-on-a-chip Kidney-on-a-chip Lung-on-a-chip Heart-on-a-chip Other Organs

Major offerings-

Products Services

Dominant application areas-

Pharmaceutical & Biotechnology organizations Cosmetics Industry Academic and Research Institute Others

Organ-on-chip models play a key role in facilitating clinical trial procedures. For instance, the advanced stem cell engineering services can be incorporated into the modern OOC technology devices to develop personalized models that are capable to predict patient-specific toxicity and efficacy. This process will result in more efficient human trials with considerably reduced preclinical testing provisions.

Regional Analysis

North America, Europe, and the Asia Pacific are the primary regions driving the global organ-on-chip market. According to market research, in the year 2017, North America held a substantial market share. The growth of the region is attributed to improvement in product innovation and R&D practices, advancements in technology and the rise in healthcare and pharmaceutical applications. Further, the improvement in toxicological testing of various chemicals on the different types of organ cells is expected to drive the demand for Organ-on-chip in this region. Asia-Pacific is foreseen to register the highest growth rate during the forecast period. The healthcare and pharmaceutical organizations operating in India, China, and Japan are expected to offer growth opportunities for the OOC device manufacturers and service providers.

Important Facts

InSphero AG, one of the prominent Organ-on-chip device manufacturers, has found the 3D InSight Monkey Liver Microtissues, which resulted in the development of the organization's suite of organotypic 3D liver prototypes for efficacy testing and in vitro safety. Recently, the Wyss Institute obtained the amount of US$5.6 million from the U.S. FDA to utilize its organ-on-chip technology to examine human physiological responses towards active radiation and to evaluate the performance of drugs designed to prevent those effects.

Also Read: https://www.einpresswire.com/article/498728414/organ-on-chip-market-global-industry-analysis-and-opportunity-assessment-2019-2023

For more information or any query mail at sales@wiseguyreports.com

[saojip13]

In Vitro Lung Model Market is Expected to Reach CAGR of 16.2% by 2027

The global in vitro lung model market is expected to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018. The market is estimated to grow with a CAGR of 16.2% from 2019-2027.

Driving factors of the in vitro lung model are significant growth in research funding, and increasing adoption of 3d model systems for in vitro studies. Also, growing research on lung diseases is likely to have a positive impact on the growth of the market in the coming years. Besides, rising healthcare expenditure, and advancements in cell culture techniques is likely to have a positive effect on the growth of the market in the forecast years.

“Request your Sample PDF Report: @ https://www.alexareports.com/report-sample/2630

The cases of asthma, lung cancer, and COPD has been growing across the globe at a significant rate. Thus there is a growing need to study lung diseases specifically. Since early 2010’s the practices of creating lab-grown organ buds, mostly referred to as ‘organoids’, have become more popular. These organ buds are miniature organ-like structures that are maintained in the lab, and researchers are able to grow these organoids, which resembles human body tissues. Lung diseases, like idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), is a significant cause of death and illness worldwide. A recently published report by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California developed a new system for building lung 3D organoids to model lung disease. Moreover, Lung cancer cell lines have made a significant contribution to lung cancer research and biomedical discovery. The high similarities between lung cancer cell lines and the lung tumor helps in discovering new drug molecules. Thus the growing research on lung diseases is expected to offer broad growth opportunities for the in vitro lung model market at the global level.

The global in vitro lung model market is segmented by type, and application. On the basis of type, the market is segmented into 2D and 3D. The 3D segment is expected to dominate the type segment market as 3D cell culture gives better phenotypes insights which are poorly reproduced in conventional 2D cell culture, Based on the application, market is segmented into drug screening, toxicology, 3d model development, physiologic research, stem cell research, and regenerative medicine. Toxicology segment is expected to dominate the application segment during the forecast period.

Click Here To Get Exclusive Discount @ https://www.alexareports.com/check-discount/2630

Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), American Society of Clinical Oncology, American Type Culture Collection, Centers for Disease Control and Prevention, Canadian Lung Association and others.

Thank you for your time. You can also ask for individual chapter wise or section or region wise report version.

Follow Us:

https://www.linkedin.com/company/alexa-report

https://www.facebook.com/alexareportsinc

https://twitter.com/Alexa_Reports